Publicaciones en las que colabora con Gemma Domínguez Muñoz (30)

2015

  1. β-Cryptoxanthin synergistically enhances the antitumoral activity of oxaliplatin through ΔNP73 negative regulation in colon cancer

    Clinical Cancer Research, Vol. 21, Núm. 19, pp. 4398-4409

2014

  1. Different exosome cargo from plasma/bronchoalveolar lavage in non-small-cell lung cancer

    Genes Chromosomes and Cancer, Vol. 53, Núm. 9, pp. 713-724

2013

  1. Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients

    Cancer Science, Vol. 104, Núm. 4, pp. 437-444

2012

  1. Analysis of exosome release and its prognostic value in human colorectal cancer

    Genes Chromosomes and Cancer, Vol. 51, Núm. 4, pp. 409-418

2011

  1. EPAS1 mRNA in plasma from colorectal cancer patients is associated with poor outcome in advanced stages

    Oncology Letters, Vol. 2, Núm. 4, pp. 719-724

  2. Prognostic impact of ΔTAp73 isoform levels and their target genes in colon cancer patients

    Clinical Cancer Research, Vol. 17, Núm. 18, pp. 6029-6039

  3. TWIST1 is expressed in colorectal carcinomas and predicts patient survival

    PLoS ONE, Vol. 6, Núm. 3

  4. Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival

    European Respiratory Journal, Vol. 37, Núm. 3, pp. 617-623

2010

  1. Differential regulation of TP73 isoforms by 1α,25-dihydroxyvitamin D3 and survivin in human colon and breast carcinomas

    Genes Chromosomes and Cancer, Vol. 49, Núm. 12, pp. 1135-1142

2009

  1. Differences in repair of DNA cross-links between lymphocytes and epithelial tumor cells from colon cancer patients measured in vitro with the comet assay

    Clinical Cancer Research, Vol. 15, Núm. 17, pp. 5466-5472

  2. Differential genetic and functional markers of second neoplasias in Hodgkin's disease patients

    Clinical Cancer Research, Vol. 15, Núm. 15, pp. 4823-4828

  3. Extracellular tumor-related mRNA in plasma of lymphoma patients and survival implications

    PLoS ONE, Vol. 4, Núm. 12

2008

  1. Deregulated expression of miR-106a predicts survival in human colon cancer patients

    Genes Chromosomes and Cancer, Vol. 47, Núm. 9, pp. 794-802

  2. Extracellular plasma RNA from colon cancer patients is confined in a vesicle-like structure and is mRNA-enriched

    RNA, Vol. 14, Núm. 7, pp. 1424-1432

  3. Free circulating mRNA in plasma from breast cancer patients and clinical outcome

    Cancer Letters, Vol. 263, Núm. 2, pp. 312-320

  4. Levels of VEGF-A mRNA in plasma from patients with colorectal carcinoma as possible surrogate marker of angiogenesis

    Journal of Cancer Research and Clinical Oncology, Vol. 134, Núm. 11, pp. 1165-1171

  5. p73 isoforms affect VEGF, VEGF165b and PEDF expression in human colorectal tumors: VEGF165b downregulation as a marker of poor prognosis

    International Journal of Cancer, Vol. 123, Núm. 5, pp. 1060-1067

2007

  1. Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients

    Breast Cancer Research, Vol. 9, Núm. 4

  2. Prognostic value of LISCH7 mRNA in plasma and tumor of colon cancer patients

    Clinical Cancer Research, Vol. 13, Núm. 21, pp. 6351-6358

2006

  1. Analysis of the candidate tumor suppressor Ris-1 in primary human breast carcinomas

    Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 594, Núm. 1-2, pp. 78-85